ArenaSabrina University of TorinoItaly

• Drugging transcription factors: HSF1 and Brachyury
  WorkmanPaul Speaker United Kingdom
• Proffered Paper: Inhibition of WEE1 kinase activity to overcome secondary resistance to targeted therapies in colorectal cancer
  EACR25-0376
  EACR25-0376
  ArenaSabrina Presenter Italy
• Targeting chromatin proteins for therapeutic benefit in haematological malignancy
  SomervailleTim Speaker United Kingdom
• Proffered Paper: Reversing Acidic Immune Suppression in Cancer with PTT-4256, A First-In-Class Small Molecule Inhibitor of GPR65
  EACR25-0553
  EACR25-0553
  CorbinAlastair Presenter United Kingdom
• PP2A inhibitor protein CIP2A is a prime target for TNBC therapy
  WestermarckJukka Speaker Finland